BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gaziano L, Giambartolomei C, Pereira AC, Gaulton A, Posner DC, Swanson SA, Ho YL, Iyengar SK, Kosik NM, Vujkovic M, Gagnon DR, Bento AP, Barrio-Hernandez I, Rönnblom L, Hagberg N, Lundtoft C, Langenberg C, Pietzner M, Valentine D, Gustincich S, Tartaglia GG, Allara E, Surendran P, Burgess S, Zhao JH, Peters JE, Prins BP, Angelantonio ED, Devineni P, Shi Y, Lynch KE, DuVall SL, Garcon H, Thomann LO, Zhou JJ, Gorman BR, Huffman JE, O'Donnell CJ, Tsao PS, Beckham JC, Pyarajan S, Muralidhar S, Huang GD, Ramoni R, Beltrao P, Danesh J, Hung AM, Chang KM, Sun YV, Joseph J, Leach AR, Edwards TL, Cho K, Gaziano JM, Butterworth AS, Casas JP; VA Million Veteran Program COVID-19 Science Initiative. Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19. Nat Med 2021;27:668-76. [PMID: 33837377 DOI: 10.1038/s41591-021-01310-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Radhakrishnan K, Hauser ER, Polimanti R, Helmer DA, Provenzale D, McNeil RB, Maffucci A, Quaden R, Zhao H, Whitbourne SB, Harrington KM, Vahey J, Gelernter J, Levey DF, Huang GD, Gaziano JM, Concato J, Aslan M. Genomics of Gulf War Illness in U.S. Veterans Who Served during the 1990-1991 Persian Gulf War: Methods and Rationale for Veterans Affairs Cooperative Study #2006. Brain Sci 2021;11:845. [PMID: 34202057 DOI: 10.3390/brainsci11070845] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Luo S, Liang Y, Wong THT, Schooling CM, Au Yeung SL. Identifying factors contributing to increased susceptibility to COVID-19 risk: a systematic review of Mendelian randomization studies. Int J Epidemiol 2022:dyac076. [PMID: 35445260 DOI: 10.1093/ije/dyac076] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Roberti A, Chaffey LE, Greaves DR. NF-κB Signaling and Inflammation-Drug Repurposing to Treat Inflammatory Disorders? Biology (Basel) 2022;11:372. [PMID: 35336746 DOI: 10.3390/biology11030372] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
4 Yusuf AP, Zhang J, Li J, Muhammad A, Abubakar MB. Herbal medications and natural products for patients with covid-19 and diabetes mellitus: potentials and challenges. Phytomedicine Plus 2022. [DOI: 10.1016/j.phyplu.2022.100280] [Reference Citation Analysis]
5 Chen Y, Huang M, Xuan Y, Li K, Xu X, Wang L, Sun Y, Xiao L, Xu P, Kong W, Wang DW. Association between Lipid Levels and Risk for Different Types of Aneurysms: A Mendelian Randomization Study. J Pers Med 2021;11:1171. [PMID: 34834523 DOI: 10.3390/jpm11111171] [Reference Citation Analysis]
6 Sjöwall J, Azharuddin M, Frodlund M, Zhang Y, Sandner L, Dahle C, Hinkula J, Sjöwall C. SARS-CoV-2 Antibody Isotypes in Systemic Lupus Erythematosus Patients Prior to Vaccination: Associations With Disease Activity, Antinuclear Antibodies, and Immunomodulatory Drugs During the First Year of the Pandemic. Front Immunol 2021;12:724047. [PMID: 34512651 DOI: 10.3389/fimmu.2021.724047] [Reference Citation Analysis]
7 Levin MG. Circulating Lipids and COVID-19: Insights From Mendelian Randomization. Arterioscler Thromb Vasc Biol 2021;41:2811-3. [PMID: 34587759 DOI: 10.1161/ATVBAHA.121.316940] [Reference Citation Analysis]
8 Khasawneh LQ, Al-Mahayri ZN, Ali BR. Mendelian randomization in pharmacogenomics: The unforeseen potentials. Biomed Pharmacother 2022;150:112952. [PMID: 35429744 DOI: 10.1016/j.biopha.2022.112952] [Reference Citation Analysis]
9 Niemi MEK, Daly MJ, Ganna A. The human genetic epidemiology of COVID-19. Nat Rev Genet 2022. [PMID: 35501396 DOI: 10.1038/s41576-022-00478-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
10 Huang W, Xiao J, Ji J, Chen L. Association of lipid-lowering drugs with COVID-19 outcomes from a Mendelian randomization study. Elife 2021;10:e73873. [PMID: 34866576 DOI: 10.7554/eLife.73873] [Reference Citation Analysis]
11 Dorkenoo AM, Gbeasor-Komlanvi FA, Gbada K, Zida-Compaore WIC, Teou D, Konu YR, Lack F, Sadio AJ, Tchankoni MK, Dagnra AC, Ekouevi DK. Prevalence of Malaria and Covid-19 in Febrile Patients in Lomé, Togo in 2020. Acta Parasitol 2022. [PMID: 35834159 DOI: 10.1007/s11686-022-00586-6] [Reference Citation Analysis]
12 Klaric L, Gisby JS, Papadaki A, Muckian MD, Macdonald-Dunlop E, Zhao JH, Tokolyi A, Persyn E, Pairo-Castineira E, Morris AP, Kalnapenkis A, Richmond A, Landini A, Hedman ÅK, Prins B, Zanetti D, Wheeler E, Kooperberg C, Yao C, Petrie JR, Fu J, Folkersen L, Walker M, Magnusson M, Eriksson N, Mattsson-Carlgren N, Timmers PRHJ, Hwang SJ, Enroth S, Gustafsson S, Vosa U, Chen Y, Siegbahn A, Reiner A, Johansson Å, Thorand B, Gigante B, Hayward C, Herder C, Gieger C, Langenberg C, Levy D, Zhernakova DV, Smith JG, Campbell H, Sundstrom J, Danesh J, Michaëlsson K, Suhre K, Lind L, Wallentin L, Padyukov L, Landén M, Wareham NJ, Göteson A, Hansson O, Eriksson P, Strawbridge RJ, Assimes TL, Esko T, Gyllensten U, Baillie JK, Paul DS, Joshi PK, Butterworth AS, Mälarstig A, Pirastu N, Wilson JF, Peters JE. Mendelian randomisation identifies alternative splicing of the FAS death receptor as a mediator of severe COVID-19. medRxiv 2021:2021. [PMID: 33851187 DOI: 10.1101/2021.04.01.21254789] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Velavan TP, Pallerla SR, Rüter J, Augustin Y, Kremsner PG, Krishna S, Meyer CG. Host genetic factors determining COVID-19 susceptibility and severity. EBioMedicine 2021;72:103629. [PMID: 34655949 DOI: 10.1016/j.ebiom.2021.103629] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Khan M, Singh GK, Abrar S, Ganeshan R, Morgan K, Harky A. Pharmacotherapeutic agents for the management of COVID-19 patients with preexisting cardiovascular disease. Expert Opin Pharmacother 2021;:1-20. [PMID: 34464223 DOI: 10.1080/14656566.2021.1960311] [Reference Citation Analysis]
15 Battistoni A, Volpe M. Repurposing Cardio-Metabolic Drugs to Fight Covid19. High Blood Press Cardiovasc Prev 2021;28:419-23. [PMID: 34524680 DOI: 10.1007/s40292-021-00475-5] [Reference Citation Analysis]
16 Hassan J, Haigh C, Ahmed T, Uddin MJ, Das DB. Potential of Microneedle Systems for COVID-19 Vaccination: Current Trends and Challenges. Pharmaceutics 2022;14:1066. [DOI: 10.3390/pharmaceutics14051066] [Reference Citation Analysis]
17 Peloso GM, Tcheandjieu C, Mcgeary JE, Posner DC, Ho Y, Zhou JJ, Hilliard AT, Joseph J, O’donnell CJ, Efird JT, Crawford DC, Wu W, Arjomandi M, Sun YV, Assimes TL, Huffman JE; VA Million Veteran Program COVID-19 Science Initiative. Genetic Loci Associated With COVID-19 Positivity and Hospitalization in White, Black, and Hispanic Veterans of the VA Million Veteran Program. Front Genet 2022;12:777076. [DOI: 10.3389/fgene.2021.777076] [Reference Citation Analysis]
18 Raza RZ, Abbasi SW. An Evolutionary Insight Into the Heterogeneous Severity Pattern of the SARS-CoV-2 Infection. Front Genet 2022;13:859508. [PMID: 35391792 DOI: 10.3389/fgene.2022.859508] [Reference Citation Analysis]
19 Schulert GS, Blum SA, Cron RQ. Host genetics of pediatric SARS-CoV-2 COVID-19 and multisystem inflammatory syndrome in children. Curr Opin Pediatr 2021;33:549-55. [PMID: 34534994 DOI: 10.1097/MOP.0000000000001061] [Reference Citation Analysis]
20 Li J, Wang Y, Liu Y, Zhang Z, Zhai Y, Dai Y, Wu Z, Nie X, Du L. Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review. Eur J Med Res 2022;27:26. [PMID: 35193695 DOI: 10.1186/s40001-022-00647-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Ma Y, Qiu F, Deng C, Li J, Huang Y, Wu Z, Zhou Y, Zhang Y, Xiong Y, Yao Y, Zhong Y, Qu J, Su J. Integrating single-cell sequencing data with GWAS summary statistics reveals CD16+monocytes and memory CD8+T cells involved in severe COVID-19. Genome Med 2022;14:16. [PMID: 35172892 DOI: 10.1186/s13073-022-01021-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]